Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06336642 · ClinicalTrials.gov registry record · Phase 2
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
A Phase 2 study of Dyspnea, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06336642: Recruiting Phase 2 study of Dyspnea, sponsored by M.D. Anderson Cancer Center.
NCT06336642 is a Phase 2 study of Dyspnea that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 150 participants, below the 299-participant average among 23 other Dyspnea trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06336642, a Phase 2 study of Dyspnea, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness of breath in patients with cancer.
Primary Outcome
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)
Conditions Studied
Interventions
- BEHAVIORAL SPOT-ON Early Start
- BEHAVIORAL SPOT-ON Delayed Start
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-06-11 |
| Est. Completion | 2032-03-31 |
| Phase | Phase 2 |
What NCT06336642 shows while recruiting
NCT06336642 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 299-participant average among 23 other Dyspnea trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Dyspnea appearing as the primary indexed condition, and to 2 interventions - of which SPOT-ON Early Start is the first listed.
NCT06336642 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06336642 about?
NCT06336642 is a clinical study titled "Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology". To learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness of breath in patients with cancer.
What is the current status of trial NCT06336642?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2024-06-11. Estimated completion is 2032-03-31.
What conditions does trial NCT06336642 study?
This clinical trial studies the following conditions: Dyspnea.
What interventions are being tested in trial NCT06336642?
The interventions under investigation include: SPOT-ON Early Start (BEHAVIORAL), SPOT-ON Delayed Start (BEHAVIORAL).
Who is sponsoring clinical trial NCT06336642?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06336642 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06336642's enrollment target sits among peer trials
150 6th of 23 higher than 18 of 23 other Dyspnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dyspnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
RECRUITING · Phase 2
-
Dexamethasone in Controlling Dyspnea in Patients With Cancer
ACTIVE NOT RECRUITING · Phase 2
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
RECRUITING
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI